Company Search:
Advanced Search
Sponsored Links
Corestem Inc Company Snapshot
Corestem Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Corestem Inc with three other companies in this sector in South Korea: Eu Biologics Co Ltd (2018 sales of 24.89 billion Korean Won [US$21.03 million] of which 91% was OCV), ISU Abxis Company Limited (16.75 billion Korean Won [US$14.15 million] of which 99% was Antibody Medicine), and Alteogen Inc (13.70 billion Korean Won [US$11.58 million] of which 100% was Biotechnology Research&Development).

Sales Analysis. Corestem Inc reported sales of 22.32 billion Korean Won (US$18.86 million) for the year ending December of 2018. This represents an increase of 23.3% versus 2017, when the company's sales were 18.09 billion Korean Won. Sales of the Clinical Trial Agent saw an increase of 26.3% in 2018, from 15.40 billion Korean Won to 19.45 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Corestem Inc
  Stock Performance Chart for Corestem Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 9,240.00
(Figures in Korean Won)
1 Week 2.2%   13 Weeks 2.2%  
4 Weeks -4.0%   52 Weeks -35.6%  
Corestem Inc Key Data:
  Ticker: 166480 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 22,316,891,009
(Year Ending Jan 2019).
Employees: 40
  Currency: Korean Won Market Cap: 145,229,145,600
  Fiscal Yr Ends: December Shares Outstanding: 15,717,440
  Share Type: Common Closely Held Shares: 4,858,595
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.